Literature DB >> 20936370

Predictive value of POSSUM and ACPGBI scoring in mortality and morbidity of colorectal resection: a case-control study.

Pascal H E Teeuwen1, A J A Bremers, J M M Groenewoud, C J H M van Laarhoven, R P Bleichrodt.   

Abstract

BACKGROUND: Preoperative risk prediction to assess mortality and morbidity may be helpful to surgical decision making. The aim of this study was to compare mortality and morbidity of colorectal resections performed in a tertiary referral center with mortality and morbidity as predicted with physiological and operative score for enumeration of mortality and morbidity (POSSUM), Portsmouth POSSUM (P-POSSUM), and colorectal POSSUM (CR-POSSUM). The second aim of this study was to analyze the accuracy of different POSSUM scores in surgery performed for malignancy, inflammatory bowel diseases, and diverticulitis. POSSUM scoring was also evaluated in colorectal resection in acute vs. elective setting. In procedures performed for malignancy, the Association of Coloproctology of Great Britain and Ireland (ACPGBI) score was assessed in the same way for comparison.
METHODS: POSSUM, P-POSSUM, and CR-POSSUM predictor equations for mortality were applied in a retrospective case-control study to 734 patients who had undergone colorectal resection. The total group was assessed first. Second, the predictive value of outcome after surgery was assessed for malignancy (n = 386), inflammatory bowel diseases (n = 113), diverticulitis (n = 91), and other indications, e.g., trauma, endometriosis, volvulus, or ischemia (n = 144). Third, all subgroups were assessed in relation to the setting in which surgery was performed: acute or elective. In patients with malignancy, the ACPGBI score was calculated as well. In all groups, receiver operating characteristic (ROC) curves were constructed.
RESULTS: POSSUM, P-POSSUM, and CR-POSSUM have a significant predictive value for outcome after colorectal surgery. Within the total population as well as in all four subgroups, there is no difference in the area under the curve between the POSSUM, P-POSSUM, and CR-POSSUM scores. In the subgroup analysis, smallest areas under the ROC curve are seen in operations performed for malignancy, which is significantly worse than for diverticulitis and in operations performed for other indications. For elective procedures, P-POSSUM and CR-POSSUM predict outcome significantly worse in patients operated for carcinoma than in patients with diverticulitis. In acute surgical interventions, CR-POSSUM predicts mortality better in diverticulitis than in patients operated for other indications. The ACPGBI score has a larger area under the curve than any of the POSSUM scores. Morbidity as predicted by POSSUM is most accurate in procedures for diverticulitis and worst when the indication is malignancy.
CONCLUSION: The POSSUM scores predict outcome significantly better than can be expected by chance alone. Regarding the indication for surgery, each POSSUM score predicts outcome in patients operated for diverticulitis or other indications more accurately than for malignancy. The ACPGBI score is found to be superior to the various POSSUM scores in patients who have (elective) resection of colorectal malignancy.

Entities:  

Mesh:

Year:  2010        PMID: 20936370      PMCID: PMC3035786          DOI: 10.1007/s11605-010-1354-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


Introduction

A large number of scoring systems to assess patient’s risks of complications or death have been developed. The physiological and operative score for enumeration of mortality and morbidity (POSSUM) was reported to be the most appropriate of the scores currently available for general surgical practice.1 It uses 12 physiological and 6 operative variables to give a calculated risk of morbidity and death. POSSUM was intended to be used in a comparative surgical audit. It was applied to a number of surgical procedures, including vascular (V-POSSUM),2 oesophagogastric (O-POSSUM)3 or colorectal (CR-POSSUM)4 surgery. Since the introduction of POSSUM in 1991 by Copeland et al.,5 several studies have shown the POSSUM score to overestimate the mortality risk.6–8 The Portsmouth POSSUM was proposed to improve the predictive value of the initial model and has been primarily validated on patients undergoing vascular surgery.8–10 In 2003, the Association of Coloproctology of Great Britain and Ireland (ACPGBI) developed its own scoring system for surgical patients with colorectal cancer. The ACPGBI score is supposed to be easier to use than the three POSSUM models.11,12 The first aim of this study was to assess the role of POSSUM in surgical audit. For this purpose, observed mortality and morbidity of colorectal resections performed in a tertiary referral centre were compared with mortality and morbidity as predicted with POSSUM, P-POSSUM, and CR-POSSUM scores and the ACPGBI score for patients operated on colorectal cancer. The second aim of this study was to examine the accuracy of the various POSSUM scores for individual risk prediction in surgery performed for malignancy, inflammatory bowel diseases, and diverticulitis.

Methods

Inclusion

A retrospective case–control study was performed of all patients older than 15 years undergoing colorectal resection between January 2003 and January 2008 in the Radboud University Nijmegen Medical Centre. Surgical interventions were performed in an elective or acute setting. Acute operation was defined as surgical interventions after emergency admission. All other operations were classified as elective.

Data Extraction

The following data were extracted from the medical records: demographics, body mass index, coexistent morbidity, use of immunosuppressive medication, American Society of Anesthesiology (ASA) grade, indication and type of surgery, type of anastomosis, surgical re-intervention (laparotomy, not radiological drainage), hospital stay, POSSUM, Portsmouth POSSUM (P-POSSUM), colorectal POSSUM (CR-POSSUM), morbidity predicted by POSSUM, postoperative mortality, and morbidity. Morbidity was defined as an unexpected event within 30 days after surgery, which was harmful for the patient’s health and required a change of therapeutic strategy. Complications were classified as defined by POSSUM (http://www.sfar.org/scores2/possum2.html). Mortality was defined as any death within 30 days after surgical intervention. ACPGBI scores were calculated in patients who had colorectal resection for histological proven cancer.

POSSUM and ACPGBI

The POSSUM score comprises a physiological and an operative component. The physiological score is based on 12 variables to be assessed in different grades. The operative severity score uses six variables. The definitive POSSUM score is calculated with the physiological as well as the operative severity score. (http://www.sfar.org/scores2/possum2.html, http://www.riskprediction.org.uk/) According to the literature on POSSUM, a normal grade was used if a variable was not available. The ACPGBI score, developed for oncologic resections, uses multifactorial logistic regression analysis to adjust for multiple risk factors, their interactions, and the clustering of adverse outcome. It is the result of a nationwide attempt in the UK to provide accurate risk adjusted outcomes involving over 8.000 patients from 77 centers. The ACPGBI score assesses five operative variables: age, cancer resection, ASA grade, Dukes’ stage, and operative urgency (http://www.riskprediction.org.uk/).

Outcome

The (P-, CR-) POSSUM-predicted mortality and morbidity was compared with the observed mortality and morbidity. Subgroup analysis was made for operations performed for carcinoma, inflammatory bowel disease, diverticulitis, and other indications, e.g., trauma, endometriosis, volvulus, or ischemia. Primary outcome was mortality. Secondary outcome measures were morbidity, (POSSUM-) complications, and hospital stay.

Statistical Analysis

Receiver operating characteristic (ROC) curves were constructed of each group analyzed in order to examine sensitivity and specificity of each POSSUM score. Areas under the curves were compared within and between subgroups. Analysis of ROC curves is a widely accepted method to investigate the properties of a diagnostic test. The area under the curve (AUC) measures the ability of the test to correctly classify those with and without a disease. Comparing the AUC in several subgroups and for different POSSUM scores therefore is the most appropriate manner to distinguish the diagnostic abilities between certain POSSUM scores in a specific subgroup or between subgroups for a specific POSSUM score.

Results

From January 2003 to January 2008, colorectal resection was performed in 734 patients: 385 women (52.5%) and 349 men (47.5%). The mean age was 58.4 years (±16.8; range, 16–96 years). In 386 (52.5%) patients, the indication for surgery was malignancy, in 113 (15.4%) inflammatory disease, and 91 (12.4%) diverticulitis. One hundred forty-four (19.6%) patients underwent colorectal surgery for other reasons: intestinal ischemia, volvulus, trauma, endometriosis, or carcinoma of urogenital or gynecologic origin. The most frequent surgical procedures were resection of the sigmoid (23.2%) and right hemicolectomy (19.8%; Table 1). Elective operations were performed in 555 patients (74.9%), and 179 (25.1%) were operated in an acute setting. The number of patients who had one or more surgical re-interventions was 152 (20.7%; Table 2).
Table 1

Demographics and performed procedures in the different subgroups

Type of surgeryMalignancyInflammatory bowel diseaseDiverticulitisOtherTotal
ElectiveAcuteElectiveAcuteElectiveAcuteElectiveAcute
n 33551932050417767734
Male1772540521212434349
Female15826531529205333385
Age (years)65.4 (12.8)a 64.7 (15.6)40.3 (14.3)42.3 (16.0)58.2 (12.0)58.7 (15.9)49.4 (15.1)58.5 (17.9)58.4 (16.8)
Body mass index (kg/m2)25.2 (4.3)24.7 (3.7)23.5 (4.3)21.7 (3.5)26.3 (4.4)25.3 (4.0)25.9 (4.9)23.7 (2.8)24.8 (4.2)
ASA2.1 (0.7)2.2 (0.7)1.9 (0.5)2.2 (0.8)2.0 (0.8)1.9 (0.8)2.1 (0.8)2.7 (1.0)2.1 (0.7)
Right hemicolectomy99165005713145
Left hemicolectomy256314021565
Transversum resection11321205933
Ileocoecal resection195551545711121
Sigmoid resection52124235301521171
(Sub-)total colectomy354171106569
Rectosigmoid resection9457041163130

aNumbers in parentheses are the standard deviations

Table 2

POSSUM scores, observed mortality and morbidity, re-intervention rate, and hospital stay in the different subgroups

Type of surgeryMalignancyInflammatory bowel diseasesDiverticulitisOtherTotal
ElectiveAcuteElectiveAcuteElectiveAcuteElectiveAcuteElectiveAcuteTotal
n 33551932050417767555179734
Predicted mortality (%)
 POSSUM14.524.66.717.38.822.09.325.510.724.417.0
 P-POSSUM5.412.22.35.72.810.82.912.43.711.25.9
 CR-POSSUM3.98.71.33.02.18.41.67.92.57.74.0
Observed mortality (%)27 (8.1)7 (13.5)1 (1.1)1 (5.0)3 (6.0)6 (14.6)4 (5.2)16 (23.9)35 (6.3)30 (16.7)65 (8.9)
Predicted morbidity (%)50.764.129.645.235.958.835.764.740.161.046.0
Observed morbidity (%)130 (38.8)18 (35.3)32 (34.4)10 (50.0)18 (36.0)16 (39.0)32 (41.6)33 (49.3)212 (38.2)77 (43.0)289 (39.4)
Wound hemorrhage222
Deep hemorrhage6311119413
Chest infection146522153261238
Wound infection197817447381957
Urinary infection17631133241034
Deep infection15264488331447
Septicaemia98121314121729
Pyrexia of unknown origin111
Wound dehiscence91221411819
Deep venous thrombosis and pulmonary embolus61188
Cardiac failure82412291019
Impaired renal function31111347
Hypotension211224
Respiratory failure2311122461016
Anastomotic leakage295814249451762
Total complications14144371522222946229127356
Re-intervention5611165910202510151152
Hospital stay (median days) (range)10 (2–127)11 (2–150)8 (1–55)7 (1–64)9 (3–57)8 (3–61)12 (1–59)15 (5–132)10 (1–127)12 (1–150)10 (1–150)
Demographics and performed procedures in the different subgroups aNumbers in parentheses are the standard deviations POSSUM scores, observed mortality and morbidity, re-intervention rate, and hospital stay in the different subgroups Morbidity was 289 in 734 (39.4%). The total number of complications amounted 356, so the mean number of complications per patient is 1.7. Among electively operated patients, 212 (38.2%) had one or more complications. Seventy-seven (43.0%) patients, operated on in an acute setting, had an unfavorable postoperative course. The most common complications were anastomotic leakage, surgical site infection, pulmonary, and urinary infections. Mean morbidity as predicted by POSSUM was 46.0% (Table 2). Sixty-five patients (8.9%) died within 30 days after surgery (Tables 2 and 3). The predicted mortality by POSSUM was 17.0%, Portsmouth POSSUM 5.9%, and colorectal-POSSUM 4.0%. In the total population as well as the subgroups (except the group with patients operated for inflammatory bowel diseases), POSSUM, P-POSSUM, and CR-POSSUM had a significantly larger predictive value for outcome after (elective and acute) colorectal surgery than can be expected by chance alone (P < 0.001). Within the total population (Fig. 1), as well as in all four subgroups (Fig. 2), there is no difference in the area under the curve between the POSSUM, P-POSSUM, and CR-POSSUM scores. In the subgroup analysis, smallest areas under the ROC curve are seen in operations performed for malignancy (0.65; 0.65; 0.65). This is significantly worse than in the diverticulitis group (0.86, P = 0.01; 0.88, P < 0.001; and 0.89, P = 0.02, respectively) and in operations performed for other indications (0.80, P = 0.03; 0.80, P = 0.03; and 0.79, P = 0.03, respectively). For elective procedures, P-POSSUM and CR-POSSUM predictions are significantly worse in patients operated for carcinoma than in patients with diverticulitis (0.61 vs. 0.85, P = 0.02, and 0.63 vs.0.89, P < 0.001, respectively). For acute surgical interventions, CR-POSSUM predicts mortality better in diverticulitis than in patients operated for other indications (0.89 vs. 0.66, P = 0.02).
Table 3

Causes of mortality

Type of surgeryMalignancyInflammatory bowel diseasesDiverticulitisOtherTotal
ElectiveAcuteElectiveAcuteElectiveAcuteElectiveAcuteElectiveAcuteTotal
Observed mortality2771136416353065
Respiratory insufficiency222153912
Cardiac failure3144
Abdominal sepsis
 Leakage521136612
 Disease11212257
 Ischemia212235
Change of treatment strategya 721138614
Unknown5166
Cerebrovascular accident11112
Bleeding1122
Transfusion reaction111

aDue to metastasis, progressive hematological malignancy, loss of perspective

Fig. 1

ROC total group

Fig. 2

Subgroup analysis: malignancy (a), inflammatory bowel disease (b), diverticulitis (c), and other (d)

Causes of mortality aDue to metastasis, progressive hematological malignancy, loss of perspective ROC total group Subgroup analysis: malignancy (a), inflammatory bowel disease (b), diverticulitis (c), and other (d) Within the group operated on carcinoma, 190 patients had a known histology and the ACPGBI score was calculated (Table 4). The observed mortality in this group was 4.7% and morbidity 30.5%. The ACPGBI score predicted a mortality rate of 5.55% (±4.48). Twenty-seven of the 190 performed procedures were in an acute setting.
Table 4

ACPGBI score in 190 patients with carcinoma

 Carcinoma
N 190
Male/female108:82
Age (mean ± SD, range)66 ± 12.2 (33–89)
Elective/acute163:27
ASA (mean ± SD)2.11 ± 0.73
Observed mortality (%)9 (4.7)
Observed morbidity (%)58 (30.5)
ACPGBI score (mean ± SD)5.55 ± 4.48
ACPGBI score in 190 patients with carcinoma The ACPGBI score, designed for oncologic colorectal resections, has a larger area under the curve than any of the POSSUM scores (0.854, P < 0.001; Fig. 3). The same applies to oncologic resections performed in the elective setting (P < 0.001). ACPGBI was found not to be superior to POSSUM (P = 0.83), P-POSSUM (P = 0.56), and CR-POSSUM (P = 0.84) in acute oncologic surgery. Fourteen out of 65 patients (21.5%) died after a change in treatment policy due to extensive oncological disease (n = 11) or the lack of perspective on a acceptable outcome (n = 3). Morbidity as predicted by POSSUM is most accurate in procedures for diverticulitis (0.757) and worst when the indication is malignancy (0.532).
Fig. 3

Predictive value of ACPGBI score on outcome after colorectal resection for malignancy

Discussion

When POSSUM is applied for individual risk prediction in patients undergoing colorectal resections for malignancy, inflammatory bowel diseases, or diverticulitis, the most accurate mortality predictions with any of the POSSUM scores was in patients with diverticulitis. The ACPGBI score is found to be superior to POSSUM scoring in patients who had (elective) resections of colorectal cancers.

POSSUM and Surgical Audit

One of the main concerns in POSSUM scoring is its overestimation of mortality. The mortality rate predicted by POSSUM (17.0%) was double the observed mortality in our total study population (8.9%). The drawbacks of the original POSSUM score led to the development of Portsmouth POSSUM and colorectal POSSUM. In our study, both scores underestimated the mortality risk (5.9% and 4.0%, respectively). Several reasons can be pointed out. First, the primary studies on POSSUM extend their analyses back to the early 1990s and are less likely to represent current practice.13 Better understanding of diseases and improvements in diagnostic and therapeutic techniques have lowered mortality rates. Regarding surgical practice, developments such as laparoscopic intervention and enhanced recovery programs have caused a decrease in mortality.14 Hence, mathematical prediction models may be outdated. Law et al.15 reported overprediction of the POSSUM scores for laparoscopic colorectal resections. In converted controls, however, POSSUM scoring was reliable, which implies a discrepancy in predictive value due to operative technique. Second, POSSUM was originally developed with patients in the UK. However, outcomes may vary with other countries or high-volume specialized centers.16,17 Third, surgery got more and more specialized over time. The original POSSUM score was designed for the general surgical patient. The accuracy of these models is under discussion due to the use of mixed patient populations. More recently, several studies specify risk prediction for different subgroups.13 In our opinion, the main argument against the use of POSSUM in surgical audit is found in the validation as a risk prediction model. Nearly all reports on POSSUM scoring validate the score on their own series, which leads to different conclusions of reports regarding over- or underpredicting of the scores. Patient selection, local facilities, and skills may be confounding factors. This is illustrated by a broad range of observed vs. expected ratios in the literature (Table 5). In our opinion, risk prediction models need to be validated to a “gold standard” in order to allow comparative audit. Since reports on surgical outcome differ and definitions of adverse outcome may vary, this desired standard may be unrealistic. Russell18 and Ferjani11 have stated that a system with standard definitions is mandatory before clinical performance can be compared between health care systems and institutions. A proper and uniform definition of mortality is essential in risk prediction. Most studies on POSSUM describe mortality as primary outcome only. As Brooks et al.6 pointed out, the majority of surgical procedures carry a low risk of death. However, along with decreasing mortality rates, the relevance of predicting morbidity is increasing. POSSUM also predicts the chance that a patient develops one or more complications with only moderate accuracy (area under the curve 0.53–0.76).
Table 5

Observed/expected ratios in the literature

AuthorPOSSUMP-POSSUMCR-POSSUMACPGBIMortality
POSSUMO/EP-POSSUMO/ECR-POSSUMO/E
Malignancy
Oomen29 10.60.163.80.453.80.451.7
Slim7 13.30.285.50.673.7
Ferjani11 12.70.804.42.329.61.068.110.2
Ren38 5.60.182.80.354.80.201.0
Horzic39 6.71.247.51.118.3
Ugolini40 7.90.799.140.6819.46.3
Menon9 15.60.568.7
Tez27 9.00.777.80.886.9
Bromage26 1.93.371.591.256.5
Ibister41 6.70.213.50.401.4
Poon42 15.00.7511.3
Tan43 11.20.145.41.6
Ugolini44 11.20.9213.10.7910.3
Can45 13.40.275.20.693.6
Diverticulitis
Oomen29 6.30.522.21.502.31.433.3
Slim7 6.90.382.80.932.6
Oomen46 7.70.745.7
Constatinides28 21.90.4910.51.0310.01.0810.8
Observed/expected ratios in the literature Cumulative sum techniques (CUSUM), described in 1954 by Page and its first introduction in surgical practice in 1994, might encounter the drawbacks mentioned above. This technique allows one to judge whether an observed variation in performance is acceptable (i.e., probably due to chance) or whether the variation is greater than what could be expected from random variation and thus may be a cause for concern. However, acceptable and unacceptable outcome rate as type I and II error rate has to be defined first. CUSUM is helpful in the evaluation of a clinical procedure before its implementation without the drawbacks of a randomized clinical trial. Plotting of the cumulative sum has been proven valuable for examining sequential measures, detecting changes over time, and is applied as a means of assessing surgical skills of trainees. Continued surveillance using the CUSUM allows the early detection of factors that lead to an increased failure rate. Quality control and objective and quantified recording of the findings meet the recommended criteria for medical audit.19–23 Predictive value of ACPGBI score on outcome after colorectal resection for malignancy

POSSUM and Individual Risk Prediction

By tailoring POSSUM to patient- and procedure-specific assessment, it becomes a tool that can help inform the individual patient on a certain procedure and the risk on adverse outcome. Several studies reported the value of POSSUM in surgery for colorectal cancer.9,17,24–27 Tekkis et al.4 developed the colorectal POSSUM and differentiated for elective or acute procedures and procedures performed for malignancy or no malignancy. Constantinides et al.28 studied the value of POSSUM scoring in patients with complicated diverticulitis and concluded that CR-POSSUM was more accurate to predict outcome than (P-)POSSUM. Oomen et al.29 retrospectively compared the different POSSUM scores in 241 patients undergoing elective resection of the sigmoid for carcinoma or diverticular disease. Although patients with diverticular disease had a higher score than patients with malignancy, mortality rate did not differ. It was concluded that none of the POSSUM scores was predictive of disease-specific mortality. However, we found significant differences in POSSUM scoring related to the indication of surgery. All POSSUM scores predicted outcome more accurately in patients with diverticular disease than in patients operated on colorectal cancer. Within the subgroup of patients with diverticular disease, we could not define a superior POSSUM score. POSSUM, P-POSSUM, and CR-POSSUM scores also predicted equally in patients with colorectal cancer. In our opinion, disease-specific patient and operative variables should be included to improve the scores. Furthermore, patients are getting older and preexistent morbidity is likely to increase. In our series, a larger variation of the various POSSUM scores is found in octogenarians (Fig. 4). This is in accordance with Slim et al.6 who studied risk prediction by POSSUM and the AFC index (Association Française de Chirurgie). It is unclear whether the introduction of more extensive cardiac and pulmonary risk indexes might further improve the predictive accuracy of POSSUM scoring. It may further complicate POSSUM scoring. The AFC index is a simpler instrument without any mathematical formulas. It uses only four independent preoperative factors and is found to be as predictive as P-POSSUM.
Fig. 4

Observed and predicted mortality related to age group

Observed and predicted mortality related to age group

Malignant Colorectal Disease

All mean POSSUM scores were higher in the carcinoma group than in diverticulitis, whilst observed mortality rates were comparable. ACPGBI scoring was found to be superior in predicting mortality after resection of colorectal cancer both in elective and acute interventions, which is consistent with the literature.11,30 Thirty-seven out of 386 patients operated for colorectal malignancy (9.6%) had known metastasis. Mortality rate was 29.7% (11/37); all patients died as consequence of a change to tender loving care due to a lack of perspective on a reasonable outcome (Table 3). Mean POSSUM, P-POSSUM, and CR-POSSUM score in the deceased group were lower than in patients who survived (respectively 11.7 vs. 21.1, P = 0.02; 3.9 vs. 7.8, P = 0.05; and 2.5 vs. 3.6, P = 0.07). Although based on a small population, these results demonstrate the insufficient predictive value of POSSUM scoring in patients with extensive oncological disease. Patients with colorectal cancer are likely to be immunosuppressed due to elderly age, nutritional status, and the colorectal cancer itself.31,32 The Dukes’ classification is too coarse to reflect today’s pathologists’ power to detect disease parameters in cancer.29 Implementation of nutritional status in POSSUM might help improve the area under the curve in malignancy.4,7,26 Both suggestions for improving POSSUM scoring need further research. Question remains whether or not these patients have to be taken into account in validating risk prediction models. Well-informed patients with advanced cancers may trade off a short-term risk in exchange for cancer cure. In this population, the risks of resectional surgery may outweigh the benefits of a simpler and possibly safer palliative operation, but this requires reliable risk estimations.12

Inflammatory Bowel Diseases

No previous studies evaluated POSSUM scoring in patients with inflammatory bowel disease. Due to the view of the physiological variables included in POSSUM, the younger, relatively healthy patient with inflammatory bowel disease is likely to have a different score than the elderly with an extensive medical history operated for colorectal carcinoma. Patients with colitis often have an increased white blood cell count and low levels of hemoglobin or albumin, reflecting disease activity. Furthermore, these patients often use immunosuppressive medication and have a poor nutritional status, which is found to increase adverse outcome after surgery.33 We found lowest POSSUM scores in this subgroup for mortality, which corresponded with the observed death rate. However, morbidity was underestimated by POSSUM. Younger age and the absence of cardiopulmonary comorbidity may explain the capability to overcome postoperative complications. POSSUM scoring for IBD may require a more prominent role of age, use of medication, nutritional status, level of hemoglobin, albumin, and white blood cell count.26 Calibration of POSSUM for patients with inflammatory bowel disease may be hard since recent review showed improved outcome of surgery to be highly dependent on accurate timing of the surgery and better perioperative care.34

Diverticular Disease

The most reliable predictions as demonstrated by the highest areas under the curve were found for patients with diverticulitis. The observed mortality was considerably higher than in patients operated for inflammatory bowel diseases and almost similar to patients with carcinomas. Patients with diverticulitis had the highest body mass indexes and were operated urgently more often, both associated with an increased complication rate.35–37 Left-sided resections were more frequently performed in patients with diverticular disease (81.3%) than in malignancy (50.3%) and inflammatory bowel diseases (15%). Left-sided resections are known to cause more complications.33 Another explanation may be patient selection. High-risk patients with diverticular disease may be withheld from surgery, whereas a malignant indication for surgery will not allow a conservative treatment strategy. Accurate definition of high-risk patients is essential. Body mass index, operative urgency, and degree of peritoneal contamination may be important variables in order to calibrate POSSUM scoring for diverticulitis. This study questions the role of POSSUM for the comparison of clinical performance between health care institutes. Poor definitions of surgical outcome and problematic validation of this risk prediction model are the main objections to use POSSUM for surgical audit. In its present form, POSSUM scoring should not be used for medical decision making in individual patients either. Future investigation needs to point out whether further calibration of POSSUM is feasible, or that alternative risk prediction models need to be developed. One solution may be for models to be more disease-specific.
  45 in total

1.  An evaluation of the POSSUM surgical scoring system.

Authors:  M S Whiteley; D R Prytherch; B Higgins; P C Weaver; W G Prout
Journal:  Br J Surg       Date:  1996-06       Impact factor: 6.939

2.  Evaluation of outcome of laparoscopic colorectal resection with POSSUM, Portsmouth POSSUM and colorectal POSSUM.

Authors:  W L Law; C M Lam; Y M Lee
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

Review 3.  Quality control of surgical and interventional procedures: a review of the CUSUM.

Authors:  David J Biau; Mathieu Resche-Rigon; Gaëlle Godiris-Petit; Rémy S Nizard; Raphaël Porcher
Journal:  Qual Saf Health Care       Date:  2007-06

4.  Scoring systems: predictive accuracy through specificity.

Authors:  Madeleine Poirier; N Joseph Espat
Journal:  Lancet Oncol       Date:  2007-04       Impact factor: 41.316

Review 5.  Risk scoring in surgical patients.

Authors:  H J Jones; L de Cossart
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

6.  Validation of the CR-POSSUM risk-adjusted scoring system for major colorectal cancer surgery in a single center.

Authors:  Stephen J Bromage; William J Cunliffe
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

7.  Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models.

Authors:  Samar Al-Homoud; Sanjay Purkayastha; Omer Aziz; Jason J Smith; Michael D Thompson; Ara W Darzi; Jeffrey D Stamatakis; Paris P Tekkis
Journal:  Surg Oncol       Date:  2004 Aug-Nov       Impact factor: 3.279

Review 8.  Systematic review of the quality of surgical mortality monitoring.

Authors:  E M Russell; J Bruce; Z H Krukowski
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

9.  Colorectal surgery in octogenarian patients--outcomes and predictors of morbidity.

Authors:  K Y Tan; Y Kawamura; K Mizokami; J Sasaki; S Tsujinaka; T Maeda; F Konishi
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

10.  Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM.

Authors:  P P Tekkis; P McCulloch; J D Poloniecki; D R Prytherch; N Kessaris; A C Steger
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

View more
  6 in total

1.  CR-Possum-Can It Be Used to Predict Morbidity? A Single-Centre Retrospective Study.

Authors:  Viswakumar Prabakaran; Thamizhmathi Thangaraju; Anil C Mathew; Vimalkumar Govindan; Vignesh Kannan; Tracy Rosalin Poulose
Journal:  Indian J Surg Oncol       Date:  2018-12-17

2.  A model predicting operative mortality in the UK has only limited value in Denmark.

Authors:  Thea Helene Degett; Ole Roikjær; Lene Hjerrild Iversen; Ismail Gögenur
Journal:  Int J Colorectal Dis       Date:  2017-12-26       Impact factor: 2.571

3.  30-day mortality after elective colorectal surgery can reasonably be predicted.

Authors:  A C Murray; C Mauro; J Rein; R P Kiran
Journal:  Tech Coloproctol       Date:  2016-07-15       Impact factor: 3.781

4.  Australasian ACPGBI risk prediction model for 30-day mortality after colorectal cancer surgery.

Authors:  S Wilkins; K Oliva; E Chowdhury; B Ruggiero; A Bennett; E J Andrews; O Dent; P Chapuis; C Platell; C M Reid; P J McMurrick
Journal:  BJS Open       Date:  2020-09-28

5.  Postoperative 30-day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data.

Authors:  S de Vries; D B Jeffe; N O Davidson; A D Deshpande; M Schootman
Journal:  Cancer Causes Control       Date:  2014-08-08       Impact factor: 2.506

6.  Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older.

Authors:  Jue-feng Wan; Ji Zhu; Gui-chao Li; Wen-jie Sun; Zhen Zhang
Journal:  Oncotarget       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.